An IVF Embryo Test Aims to Prevent Miscarriages: Is It Worth It?
By Laura Hercher,
Scientific American
| 06. 01. 2022
In clinics today, fertility patients using in vitro fertilization (IVF) are routinely advised to pay for an expensive supplemental test called preimplantation genetic testing for aneuploidy (PGT-A), in which a handful of cells are removed from the embryo to examine their DNA. For those who can afford it, PGT-A is popular because it can flag genetic abnormalities that increase the odds that a pregnancy, should it occur, will end in miscarriage.
Pervasive use of the test has also generated controversy. The authors of an April 2022 study in Human Reproduction have sparked debate and alarmed prospective parents by suggesting that many clinics are too quick to discard embryos based on PGT-A and are ignoring a growing body of evidence that some of these embryos are capable of producing a viable pregnancy.
If all of a patient’s embryos are rejected based on PGT-A results, they may lose their only chance at taking home a baby or be directed prematurely toward expensive alternative technologies such as donor eggs that would deprive them of a child genetically related to both parents. In a...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
